Protagonist Therapeutics Inc (PTGX)

Exchange
NASDAQ
Symbol
PTGX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.
Country
USA

Stock price

At close: January 2, 2026

  • Open
    86.54
  • High
    88.16
  • Low
    85.19
  • Close
    87.18
  • Volume
    751,656

Financial ratios

Dec 31, 2024